Trending...
- From Real Estate to Reel Power: H.L Woods Carves His Legacy as a Cutting-Edge Visionary Filmmaker
- SacraPod Suites Unveils AI-Powered 'Work + Rest' Smart Hospitality Model for Retrofitting Underused Motels Across the U.S
- Airwavz Solutions Appoints Monte Dube to Market Advisory Board to Strengthen Healthcare Wireless Strategy
SAN FRANCISCO - illiNews -- Nuevozen a healthcare Artificial Intelligence company developing patient risk assessment and diagnostic solutions for cancer and other serious diseases, is pleased to announce the addition of Dr. Victor Levin, a leading Neuro Oncologist in the world, to the company's medical advisory board.
Currently, Dr. Levin is a Neuro-Oncology Physician in the Department of Neurosurgery and Neuroscience, Kaiser Permanente Medical Center, Redwood City. He is also Professor Emeritus, Department of Neuro-Oncology, The University of Texas M. D. Anderson Cancer Center and Clinical Professor, Department of Neurosurgery, at UCSF School of Medicine. He built and chaired the world-renowned Neuro-Oncology program at the University of Texas M. D. Anderson Cancer Center.
More on illi News
I am deeply honored and excited to have Dr. Levin, one of the leading experts in the field of neuro-oncology, join our advisory board," stated Karan Aujla, Nuevozen' co-founder and CEO. "I look forward to working with Dr Levin to leverage his knowledge and expertise and his passion for improving patient outcome to help our team identify and develop clinical use cases of AI including volumetric analysis of infiltrative CNS tumors seen with MRI".
"I'm excited to join Nuevozen' advisory board and look forward to helping guide the company as they continue to develop their Artificial Intelligence technology," said Dr. Victor Levin. "I believe that Artificial Intelligence has the potential to improve the diagnosis of infiltrative CNS tumors and metastases and to quantify benefit of new drug therapies and other treatments for CNS tumors"
Dr. Levin founded the Society for Neuro-Oncology in 1995 and served as its first president in 1996. He has published nearly 400 peer-reviewed articles, chapters, editorials, and books including the multidisciplinary textbook, Cancer in the Nervous System. In his career, Dr. Levin received numerous awards including the Anne and Jason Farber Award for Neuro-Oncology, Gold Medal Award for Extraordinary Achievement (Society for Neuro-Oncology). He has also been listed in The Best Doctors in America, America's Top Doctors in Cancer, and America's Top Doctors for many years.
More on illi News
About Nuevozen Corp.
Founded in 2018, Nuevozen Corp. is a privately held Healthcare AI company located in San Francisco Bay area. Nuevozen' mission is to help healthcare providers in improving quality and speed of care by utilizing artificial intelligence. For additional information go to www.Nuevozen.AI
Currently, Dr. Levin is a Neuro-Oncology Physician in the Department of Neurosurgery and Neuroscience, Kaiser Permanente Medical Center, Redwood City. He is also Professor Emeritus, Department of Neuro-Oncology, The University of Texas M. D. Anderson Cancer Center and Clinical Professor, Department of Neurosurgery, at UCSF School of Medicine. He built and chaired the world-renowned Neuro-Oncology program at the University of Texas M. D. Anderson Cancer Center.
More on illi News
- READY FOR NEW BUILDS – Pond & Waterfall Construction Season Starts Now!
- Generic Trade Marks 15 Years of Leveling the Trading Field for all Futures Traders
- HeyGears Achieves Breakthrough in Multi-Material Resin 3D Printing, Overcoming Bottlenecks in Dental Manufacturing
- Levata Acquires Logiscenter to Accelerate Growth in Enterprise IT and Data Capture Solutions
- Smart Resnse Unveils Smart Resnse(SRMS) Token-Powered AI Orchestration Platform to Revolutionize Multi-Billion Dollar Market
I am deeply honored and excited to have Dr. Levin, one of the leading experts in the field of neuro-oncology, join our advisory board," stated Karan Aujla, Nuevozen' co-founder and CEO. "I look forward to working with Dr Levin to leverage his knowledge and expertise and his passion for improving patient outcome to help our team identify and develop clinical use cases of AI including volumetric analysis of infiltrative CNS tumors seen with MRI".
"I'm excited to join Nuevozen' advisory board and look forward to helping guide the company as they continue to develop their Artificial Intelligence technology," said Dr. Victor Levin. "I believe that Artificial Intelligence has the potential to improve the diagnosis of infiltrative CNS tumors and metastases and to quantify benefit of new drug therapies and other treatments for CNS tumors"
Dr. Levin founded the Society for Neuro-Oncology in 1995 and served as its first president in 1996. He has published nearly 400 peer-reviewed articles, chapters, editorials, and books including the multidisciplinary textbook, Cancer in the Nervous System. In his career, Dr. Levin received numerous awards including the Anne and Jason Farber Award for Neuro-Oncology, Gold Medal Award for Extraordinary Achievement (Society for Neuro-Oncology). He has also been listed in The Best Doctors in America, America's Top Doctors in Cancer, and America's Top Doctors for many years.
More on illi News
- Josh and Heidi Follow Up the Much Anticipated and Successful Launch of the "Spreading the Good BUZZ" Podcast with a Personal Request
- Startup Born of CTE + Depression Launches Japandi Supply House
- Revolutionary Blockchain Platform Okh Finance Announces Okh Finance(OKKH) Token Launch to Transform Global Asset Leasing Market
- Cover Girl Finalist Teisha Mechetti Questions Legitimacy of Inked Originals Competition, Demands Transparency
- Sylver's Debut Book Reveals Massive Industry Oversight
About Nuevozen Corp.
Founded in 2018, Nuevozen Corp. is a privately held Healthcare AI company located in San Francisco Bay area. Nuevozen' mission is to help healthcare providers in improving quality and speed of care by utilizing artificial intelligence. For additional information go to www.Nuevozen.AI
Source: Nuevozen
0 Comments
Latest on illi News
- Dr. John Salerno of Salerno Wellness Introduces Their New Full Body Capsule for Advanced LED Light Therapy Patient Treatments
- Digi 995 Expands Its Universe: All Three Novels Now Available in Paperback Worldwide
- Chicago: Mayor Brandon Johnson on Track to Hit Summer Youth Employment Goal with Almost 29,000 Young People Hired for Third Consecutive Year of Expanded Opportunities
- $14M Expansion Deal with Famed David Lloyd Highlights Rebrand of Sports, Entertainment and Gaming Innovation by AI Driven, Online Fan Engagement Co
- Heartfelt Dreams Foundation Launches Campaign to Build CHD Hospital
- Radarsign Tackles Intersection Safety with Launch of Grid-Free Solar LED Stop Sign
- Miami Real Estate Agent Drastically Increases Interest In Homes
- Adostics & Genmega Announce the Introduction of A-POD
- LIB and Nidec Rejoin Forces for Giant TH-0098 Temperature Humidity Test Chamber
- Digi 995 Audiobooks Officially Released: Fans Can Now Listen to the Complete Trilogy
- Naperville: Two Men Charged with Aggravated Street Racing
- Heritage at South Brunswick Offers Immediate Townhome Appointments and Special Mortgage Incentive Fast-Moving Sales
- NASA Collaborative Agreement for Supply of Thin-Film Solar Tech for Orbital Application to Advance Development of Thin-Film PV Power Beaming: $ASTI
- Exciting New Era of Sports, Entertainment & Gaming Innovation Spotlighted by Rebrand of Expanding AI Driven, Online Fan Engagement Company: SEGG Media
- Service Ninjas Debuts First-of-Its-Kind "Membership" Platform for Home Service Pros
- BIYA Forecasts 2025 Surge with ¥300M ($41.8 M USD) in Revenue and ¥25M Profit from Cloud Based HR Solutions: Baiya Intl. Group (N A S D A Q: BIYA)
- Paul E. Saperstein Co. Announces Geographic Expansion of Auction Services
- Celebrate National Beef Tallow Day with South Chicago Packing
- Florida Broker Bent Danholm Featured in the Daily Mail's U.S. Real Estate Coverage
- Robin Launches Legal Intelligence Platform to solve intelligence gap in Fortune 500 legal teams